vs

Side-by-side financial comparison of BRANDYWINE REALTY TRUST (BDN) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $127.0M, roughly 1.1× BRANDYWINE REALTY TRUST). Oncology Institute, Inc. runs the higher net margin — -5.3% vs -38.4%, a 33.1% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 4.5%). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 0.7%).

Brandywine Realty Trust is a Philadelphia-based real estate investment trust (REIT) that invests in office buildings in Philadelphia, Washington, D.C., and Austin, Texas.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

BDN vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.1× larger
TOI
$142.0M
$127.0M
BDN
Growing faster (revenue YoY)
TOI
TOI
+37.1% gap
TOI
41.6%
4.5%
BDN
Higher net margin
TOI
TOI
33.1% more per $
TOI
-5.3%
-38.4%
BDN
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
0.7%
BDN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BDN
BDN
TOI
TOI
Revenue
$127.0M
$142.0M
Net Profit
$-48.8M
$-7.5M
Gross Margin
Operating Margin
1.2%
-4.9%
Net Margin
-38.4%
-5.3%
Revenue YoY
4.5%
41.6%
Net Profit YoY
-80.4%
43.0%
EPS (diluted)
$-0.28
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDN
BDN
TOI
TOI
Q1 26
$127.0M
Q4 25
$121.0M
$142.0M
Q3 25
$121.4M
$136.6M
Q2 25
$120.6M
$119.8M
Q1 25
$121.5M
$104.4M
Q4 24
$121.9M
$100.3M
Q3 24
$131.8M
$99.9M
Q2 24
$125.3M
$98.6M
Net Profit
BDN
BDN
TOI
TOI
Q1 26
$-48.8M
Q4 25
$-36.7M
$-7.5M
Q3 25
$-25.9M
$-16.5M
Q2 25
$-88.7M
$-17.0M
Q1 25
$-27.0M
$-19.6M
Q4 24
$-44.5M
$-13.2M
Q3 24
$-165.2M
$-16.1M
Q2 24
$30.2M
$-15.5M
Gross Margin
BDN
BDN
TOI
TOI
Q1 26
Q4 25
61.3%
Q3 25
62.6%
Q2 25
62.4%
Q1 25
60.8%
Q4 24
61.2%
Q3 24
64.9%
Q2 24
63.1%
Operating Margin
BDN
BDN
TOI
TOI
Q1 26
1.2%
Q4 25
22.8%
-4.9%
Q3 25
20.8%
-5.9%
Q2 25
-34.3%
-9.4%
Q1 25
12.5%
-9.5%
Q4 24
18.0%
-11.9%
Q3 24
-7.2%
-13.9%
Q2 24
15.5%
-16.6%
Net Margin
BDN
BDN
TOI
TOI
Q1 26
-38.4%
Q4 25
-30.3%
-5.3%
Q3 25
-21.3%
-12.1%
Q2 25
-73.5%
-14.2%
Q1 25
-22.2%
-18.8%
Q4 24
-36.5%
-13.1%
Q3 24
-125.4%
-16.1%
Q2 24
24.1%
-15.7%
EPS (diluted)
BDN
BDN
TOI
TOI
Q1 26
$-0.28
Q4 25
$-0.21
$-0.04
Q3 25
$-0.15
$-0.14
Q2 25
$-0.51
$-0.15
Q1 25
$-0.16
$-0.21
Q4 24
$-0.25
$-0.14
Q3 24
$-0.96
$-0.18
Q2 24
$0.17
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDN
BDN
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$36.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$-15.7M
Total Assets
$3.6B
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDN
BDN
TOI
TOI
Q1 26
$36.2M
Q4 25
$32.3M
Q3 25
$75.5M
Q2 25
$122.6M
Q1 25
$29.4M
Q4 24
$90.2M
Q3 24
$36.5M
Q2 24
$30.4M
$9.9M
Total Debt
BDN
BDN
TOI
TOI
Q1 26
Q4 25
$2.6B
Q3 25
$2.3B
Q2 25
$2.3B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.3B
Q2 24
$2.2B
Stockholders' Equity
BDN
BDN
TOI
TOI
Q1 26
Q4 25
$792.7M
$-15.7M
Q3 25
$841.5M
$-12.3M
Q2 25
$879.8M
$-9.0M
Q1 25
$993.6M
$5.1M
Q4 24
$1.0B
$3.6M
Q3 24
$1.1B
$15.5M
Q2 24
$1.3B
$29.2M
Total Assets
BDN
BDN
TOI
TOI
Q1 26
$3.6B
Q4 25
$3.6B
$164.7M
Q3 25
$3.3B
$163.6M
Q2 25
$3.4B
$159.8M
Q1 25
$3.4B
$164.0M
Q4 24
$3.5B
$172.7M
Q3 24
$3.6B
$179.2M
Q2 24
$3.8B
$179.6M
Debt / Equity
BDN
BDN
TOI
TOI
Q1 26
Q4 25
3.23×
Q3 25
2.70×
Q2 25
2.63×
Q1 25
2.23×
Q4 24
2.13×
Q3 24
2.06×
Q2 24
1.73×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDN
BDN
TOI
TOI
Operating Cash FlowLast quarter
$3.2M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDN
BDN
TOI
TOI
Q1 26
Q4 25
$116.7M
$3.2M
Q3 25
$47.5M
$-12.6M
Q2 25
$34.4M
$-10.2M
Q1 25
$6.3M
$-5.0M
Q4 24
$181.1M
$4.2M
Q3 24
$52.2M
$819.0K
Q2 24
$48.2M
$-15.7M
Free Cash Flow
BDN
BDN
TOI
TOI
Q1 26
Q4 25
$2.2M
Q3 25
$-13.2M
Q2 25
$-11.4M
Q1 25
$-5.3M
Q4 24
$2.4M
Q3 24
$417.0K
Q2 24
$-17.5M
FCF Margin
BDN
BDN
TOI
TOI
Q1 26
Q4 25
1.5%
Q3 25
-9.7%
Q2 25
-9.5%
Q1 25
-5.1%
Q4 24
2.4%
Q3 24
0.4%
Q2 24
-17.7%
Capex Intensity
BDN
BDN
TOI
TOI
Q1 26
Q4 25
0.7%
Q3 25
0.4%
Q2 25
1.0%
Q1 25
0.3%
Q4 24
1.8%
Q3 24
0.4%
Q2 24
1.9%
Cash Conversion
BDN
BDN
TOI
TOI
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BDN
BDN

Rents$120.7M95%
Third party management fees, labor reimbursement and leasing$4.7M4%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons